Literature DB >> 20368156

Traversing the valley of death: a guide to assessing prospects for translational success.

Barry S Coller1, Robert M Califf.   

Abstract

On the basis of our experience in drug and device development, we have identified six broad categories of issues that profoundly affect the probability for successful translation of basic scientific discoveries into effective therapies. Within each category, we propose a series of questions that form the beginnings of a self-guided global risk assessment tool. Although this preliminary tool will require validation and adjustment, we offer it to stimulate a discussion about more rigorous methods for selecting and conducting translational projects.

Entities:  

Mesh:

Year:  2009        PMID: 20368156      PMCID: PMC2879158          DOI: 10.1126/scitranslmed.3000265

Source DB:  PubMed          Journal:  Sci Transl Med        ISSN: 1946-6234            Impact factor:   17.956


  24 in total

1.  Translation of basic research into useful treatments: how often does it occur?

Authors:  William F Crowley
Journal:  Am J Med       Date:  2003-04-15       Impact factor: 4.965

2.  Translation of academic discovery into societal benefit: proposal for a balanced approach--part 1.

Authors:  Jonathan S Stamler; Robert L Taber; Robert M Califf
Journal:  Am J Med       Date:  2003-11       Impact factor: 4.965

3.  The patents-based pharmaceutical development process: rationale, problems, and potential reforms.

Authors:  John H Barton; Ezekiel J Emanuel
Journal:  JAMA       Date:  2005-10-26       Impact factor: 56.272

Review 4.  Promises of biomarkers in drug development--a reality check.

Authors:  Estelle Marrer; Frank Dieterle
Journal:  Chem Biol Drug Des       Date:  2007-06       Impact factor: 2.817

5.  Patent sense.

Authors:  Paul Herrling
Journal:  Nature       Date:  2007-09-13       Impact factor: 49.962

6.  NIH program to boost pipeline for drugs to treat rare and neglected diseases.

Authors:  Bridget M Kuehn
Journal:  JAMA       Date:  2009-07-08       Impact factor: 56.272

Review 7.  Blockade of platelet GPIIb/IIIa receptors as an antithrombotic strategy.

Authors:  B S Coller
Journal:  Circulation       Date:  1995-11-01       Impact factor: 29.690

Review 8.  Systematizing serendipity for cardiovascular drug discovery.

Authors:  Peter J Schlueter; Randall T Peterson
Journal:  Circulation       Date:  2009-07-21       Impact factor: 29.690

9.  Lecithin: cholesterol acyltransferase and atherosclerosis: another high-density lipoprotein story that doesn't quite follow the script.

Authors:  Daniel J Rader
Journal:  Circulation       Date:  2009-08-03       Impact factor: 29.690

10.  Incentives for orphan drug research and development in the United States.

Authors:  Enrique Seoane-Vazquez; Rosa Rodriguez-Monguio; Sheryl L Szeinbach; Jay Visaria
Journal:  Orphanet J Rare Dis       Date:  2008-12-16       Impact factor: 4.123

View more
  27 in total

1.  Improving the efficacy of translational medicine by optimally integrating health care, academia and industry.

Authors:  Stefan R Bornstein; Julio Licinio
Journal:  Nat Med       Date:  2011-12-06       Impact factor: 53.440

2.  "Broader impacts" or "responsible research and innovation"? A comparison of two criteria for funding research in science and engineering.

Authors:  Michael Davis; Kelly Laas
Journal:  Sci Eng Ethics       Date:  2013-10-24       Impact factor: 3.525

3.  The Clinical and Translational Science Awards (CTSAs) are transforming the way academic medical institutions approach translational research: the University of Michigan Experience.

Authors:  Kenneth J Pienta; Alison L Spork; Joan Scheske
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

4.  Future translational applications from the contemporary genomics era: a scientific statement from the American Heart Association.

Authors:  Caroline S Fox; Jennifer L Hall; Donna K Arnett; Euan A Ashley; Christian Delles; Mary B Engler; Mason W Freeman; Julie A Johnson; David E Lanfear; Stephen B Liggett; Aldons J Lusis; Joseph Loscalzo; Calum A MacRae; Kiran Musunuru; L Kristin Newby; Christopher J O'Donnell; Stephen S Rich; Andre Terzic
Journal:  Circulation       Date:  2015-04-16       Impact factor: 29.690

5.  The Use of Community Engaged Research Principles to Improve Health: Community Academic Partnerships for Research.

Authors:  Joyce E Balls-Berry; Edna Acosta-Pérez
Journal:  P R Health Sci J       Date:  2017-06       Impact factor: 0.705

6.  An experimental toolbox for characterization of mammalian collagen type I in biological specimens.

Authors:  Héctor Capella-Monsonís; João Q Coentro; Valeria Graceffa; Zhuning Wu; Dimitrios I Zeugolis
Journal:  Nat Protoc       Date:  2018-02-15       Impact factor: 13.491

Review 7.  Biomarker definitions and their applications.

Authors:  Robert M Califf
Journal:  Exp Biol Med (Maywood)       Date:  2018-02

8.  Cytokine response is determined by duration of receptor and signal transducers and activators of transcription 3 (STAT3) activation.

Authors:  David A Braun; Miguel Fribourg; Stuart C Sealfon
Journal:  J Biol Chem       Date:  2012-11-19       Impact factor: 5.157

9.  Successfully accelerating translational research at an academic medical center: the University of Michigan-Coulter translational research partnership program.

Authors:  Kenneth J Pienta
Journal:  Clin Transl Sci       Date:  2010-12       Impact factor: 4.689

Review 10.  The Valley of Death in anticancer drug development: a reassessment.

Authors:  David J Adams
Journal:  Trends Pharmacol Sci       Date:  2012-03-10       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.